BiotechTube
Home/Genedrive/Ian Gilham
IG

Ian Gilham

Chairman of the Board

Genedrive

Therapeutic Areas

Infectious Disease (Antibiotic Safety)Cardiovascular/CerebrovascularPersonalized Medicine

Genedrive Pipeline

DrugIndicationPhase
Genedrive® MT-RNR1 ID KitPrevention of aminoglycoside-induced hearing loss in newbornsCommercial
Genedrive® CYP2C19 ID KitGuidance for antiplatelet therapy (e.g., clopidogrel) in stroke/ACS patientsCommercial

Leadership Team at Genedrive

DB
David Budd
Chief Executive Officer
MF
Matthew Fowler
Chief Financial Officer
JC
James Cheek
Chief Commercial Officer
View full Genedrive profile